Sin título-1.png
Dr. Luis.png

Dr. Luis Gosálbez

Managing Director and Co-Founder

The GMO-microbiome drug development landscape

Dr. Luis Gosálbez presentation showed an overview of the role of the genetic modification of microorganisms to augment or expand their native metabolic capabilities, and use them as long-term drug delivery systems, as vaccines or as gene therapy agents in a wide range of diseases, from infections to metabolic disorders to cancer.

Download our presentation at
Pharmabiotics 2022
Your file will download automatically. Check your Downloads folder